| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/19/2006 | WO2006005914A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2006005909A1 Substituted acids for the treatment of respiratory diseases |
| 01/19/2006 | WO2005113514A3 Substituted pyrimidines as inhibitors of bacterial type iii protein secretion systems |
| 01/19/2006 | WO2005095357A3 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/19/2006 | WO2005075458A8 Pyrimidine derivatives as orexin receptors antagonists |
| 01/19/2006 | US20060014960 Substituted pyridines or pyrimidines, method for their production, agents containing said substances and the use thereof as pesticides |
| 01/19/2006 | US20060014952 Method for producing 4,6-dichloro-5-fluoropyrimidine |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014766 Reacting with sodium hydroxide then calcium chloride to form calcium salt derivative; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors |
| 01/19/2006 | US20060014760 Compounds and methods of use to treat infectious diseases |
| 01/19/2006 | US20060014759 4-{3-[1-benzhydryl-5-chloro-2-(2-{[(2,6-dimethylbenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoic acid; asthma, stroke, atherosclerosis, multiple sclerosis, Parkinson's disease, arthritic disorders, rheumatic disorders, central nervous system damage resulting from stroke |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/19/2006 | US20060014742 Amide derivative |
| 01/19/2006 | US20060014644 Phenylsulfonyl ureas, process for their preparation and their use as herbicides and plant growth regulators |
| 01/19/2006 | US20060010618 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres |
| 01/19/2006 | CA2571756A1 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | CA2571750A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | CA2571748A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/18/2006 | EP1616863A1 Process for the preparation of fluorinated aromatic compounds |
| 01/18/2006 | EP1615898A1 2-aminopyrimidine derivatives and their medical use |
| 01/18/2006 | EP1615897A2 Pyrimidinone compounds as calcilytics |
| 01/18/2006 | EP1615636A1 Bicyclic compounds as nr2b receptor antagonists |
| 01/18/2006 | EP1200420B1 Process for making n-alkyl bis(thiazolyl)sulfenimides |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1721413A Barbituric acids and their preparation process and use |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1237345C Process for obtaining L-dihydroorotic acid and use thereof |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/17/2006 | US6987114 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 01/12/2006 | WO2006004925A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | WO2006003378A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | WO2006003277A1 Aromatic biaryl products, compositions containing same and use as medicines |
| 01/12/2006 | WO2006003150A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | WO2006003146A1 Quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | WO2006002802A1 Phenyl derivatives comprising an acetylene group |
| 01/12/2006 | US20060009643 ring-fluorinated aromatics by a halogen exchange reaction (halex reaction) of a plurality of halogen substituents in one stage in the presence of (N,N-dimethylimidazolidino)tetramethylguanidinium chloride or bromide catalyst, using alkali, alkaline or ammonium fluoride |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/12/2006 | US20060009476 Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof |
| 01/12/2006 | US20060009474 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009455 especially blood coagulation factor XIa and plasma kallikrein; e.g. 4-aminomethyl-[2-phenyl-1-(4-phenyl-pyridin-2-yl)-ethyl]-trans cyclohexanecarboxamide; anticoagulant, antiinflammatory agent; |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/12/2006 | CA2572797A1 A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
| 01/12/2006 | CA2572084A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572083A1 Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 01/12/2006 | CA2570169A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | CA2569826A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2568835A1 Quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2567020A1 Aromatic biaryl products, compositions containing same and use as medicines |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614672A1 An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction |
| 01/11/2006 | EP1613607A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 01/11/2006 | EP1613606A2 Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones |
| 01/11/2006 | EP1613605A1 2-substituted pyrimidines |
| 01/11/2006 | EP1613596A1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 01/11/2006 | EP1613595A2 Novel compounds and compositions as protein kinase inhibitors |
| 01/11/2006 | EP1613326A1 (3-{3-´(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino!-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 01/11/2006 | EP1613303A1 Substituted p-diaminobenzene derivatives |
| 01/11/2006 | EP1028944B1 Fluorinated naphthalene derivatives and their use in liquid crystal mixtures |
| 01/11/2006 | CN1720332A Substrates for O6-alkylguanine-DNA alkyltransferase |
| 01/11/2006 | CN1720243A Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 01/11/2006 | CN1720238A Neurologically-active compounds |
| 01/11/2006 | CN1720237A 3h-quinazolin-4-one derivatives |
| 01/11/2006 | CN1720228A Process for making risperidone and intermediates therefor |
| 01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
| 01/11/2006 | CN1718573A Heterocyclic compound |
| 01/11/2006 | CN1718572A Process for preparing ring-fluorinated aromatics |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/11/2006 | CN1235856C Process for manufacture of phenylacetic acid derivatives |
| 01/10/2006 | USRE38934 Method and reagents for N-alkylating ureides |
| 01/10/2006 | US6984757 reacting 2-[-1-amino-1-(4-flourophenyl)methylene]-4-alkyl-3-oxo-alkanoic acid ester with N-cyano-N-alkylalkanesulfonamide; HMG-Co A reductase inhibitors |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984396 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/05/2006 | WO2006000371A2 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 01/05/2006 | WO2005095358A3 Process for the preparation of aminopyrimidines |
| 01/05/2006 | WO2003031406A3 Kinase inhibitor scaffolds and methods for their preparation |
| 01/05/2006 | US20060004091 Alpha-phenoxy- or phenylthio-alkanoic acid derivatives in which the phenyl ring is substituted with an acetylene group, e.g., 2-methyl-2-{2-methyl-4-[4-(4-trifluoromethyl-phenyl)-but-3-ynylsulfanyl]-phenoxy}-propionic acid; PPAR delta and/or PPAR alpha agonists used to treat diabetes |
| 01/05/2006 | US20060004066 Method for treating ADAMTS-5-associated disease |
| 01/05/2006 | US20060004031 Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
| 01/05/2006 | US20060004030 Asthma, antiallergens; rheumatoid arthritis and atherosclerosis; anticarcinogenic agents; 2-(Benzylthio)-6-{[(1R)-2-hydroxy-1-methylethyl]amino}-4-pyrimidinol |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060003999 reduction of 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile to give 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile, hydration of intermediated to form 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide; cyclization |
| 01/05/2006 | US20060003970 Novel combi-molecules having EGFR and DNA targeting properties |
| 01/05/2006 | CA2571012A1 Tricyclic compounds and their use as mglur1 antagonists |
| 01/05/2006 | CA2570873A1 Pyrimidine urea derivatives as kinase inhibitors |
| 01/05/2006 | CA2568804A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 01/05/2006 | CA2568802A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists |
| 01/04/2006 | EP1611120A1 Novel methods for the treatment of inflammatory diseases |
| 01/04/2006 | EP1611109A1 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1611090A2 Cannabinoid receptor ligands |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1610774A2 Tie-2 modulators and methods of use |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1395585B1 Antibacterial agents |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |